SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 83 (6) , 1083-1090
- https://doi.org/10.1016/0091-6749(89)90450-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A Comparison of Loratadine, a New Nonsedating Antihistamine, with Clemastine and Placebo in Patients with Fall Seasonal Allergic RhinitisAmerican Journal of Rhinology, 1987
- Pharmacokinetics and Dose Proportionality of LoratadineThe Journal of Clinical Pharmacology, 1987
- Sedative effects of antihistaminesJournal of Allergy and Clinical Immunology, 1987
- Loratadine: Multiple‐Dose PharmacokineticsThe Journal of Clinical Pharmacology, 1987
- Loratadine (SCH29851) 40 mg Once Daily versus Terfenadine 60 mg Twice Daily in the Treatment of Seasonal Allergic RhinitisJournal of International Medical Research, 1987
- Studies on the central effects of the H1-antagonist, loratadineEuropean Journal of Clinical Pharmacology, 1987
- Antiallergic activity of loratadine, a non‐sedating antihistamineAllergy, 1986
- Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamineEuropean Journal of Pharmacology, 1986
- Pharmacologic evaluation of loratadine (SCH 29851), chlorpheniramine and placeboEuropean Journal of Clinical Pharmacology, 1986
- Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamineInflammation Research, 1984